On April 9, 2026, the 2nd Annual Meeting of the Enough is Enough Childhood Medulloblastoma Prevention Consortium brought together parents and advocates, global leaders and industry partners in Dallas, Texas. Their shared vision: to make childhood medulloblastoma a public health issue and work toward a prevention strategy, in parallel with new therapies for children already diagnosed.
The meeting, summarized in an article published in Child’s Nervous System, set three priorities: engaging the community to raise awareness and enable rapid access to samples and data; developing a simple, accessible method for collecting blood samples to identify early detection biomarkers; and making patient datasets available in real time to accelerate the identification and validation of candidate biomarkers.
MBI took part in the meeting, alongside clinicians, scientists and parent advocates from around the world who made a commitment to cure and eventually prevent medulloblastoma.
Read the full article: https://doi.org/10.1007/s00381-026-07511-6